Dallas-based life science company ReCode Therapeutics has appointed Patricia “Trisha” Millican to its board of directors, bringing with her more than 20 years of experience in the life science industry.
ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics....